Glazebrook Cristine, Garrud Paul, Avery Anthony, Coupland Carol, Williams Hywel
Behavioral Sciences Section, Division of Psychiatry, School of Community Health Sciences, Queens Medical Centre, Nottingham, NG7 2UH, UK.
Prev Med. 2006 Jun;42(6):449-54. doi: 10.1016/j.ypmed.2006.02.007. Epub 2006 Mar 31.
Rates of malignant melanoma are rising, with those people with sun-sensitive skin most at risk. Health education interventions are needed to help people protect themselves by detecting early signs of melanoma and by protecting their skin from sunburn. This study aimed to evaluate the impact of an interactive multimedia intervention "Skinsafe" on patients' knowledge about melanoma and on their skin protective behaviors.
In this cluster-randomized, controlled trial conducted in Nottinghamshire, UK, doctors and nurses in 5 family practices prescribed Skinsafe to patients with higher risk skin characteristics. Measures of melanoma knowledge, perceived risk of melanoma and reported skin protective behaviors were obtained at baseline and at 6-month follow-up from 259 patients receiving the intervention and 330 patients with higher risk skin characteristics in 5 matched control practices.
Participants had low levels of melanoma knowledge at baseline. At follow-up, the intervention group had higher knowledge scores than control (3.71 vs. 3.03, P < or = 0.001), reported more protective skin behaviors (5.36 vs. 5.06, P = 0.007) and were more likely to report mole checking (odds ratio 1.67, 95% CI 1.04 to 2.70, P = 0.035). The Skinsafe intervention was evaluated positively by patients and could be used to support melanoma health education within clinical settings.
恶性黑色素瘤的发病率正在上升,皮肤对阳光敏感的人群风险最高。需要开展健康教育干预措施,帮助人们通过发现黑色素瘤的早期迹象以及保护皮肤免受晒伤来进行自我保护。本研究旨在评估交互式多媒体干预措施“Skinsafe”对患者黑色素瘤知识及皮肤保护行为的影响。
在英国诺丁汉郡进行的这项整群随机对照试验中,5家全科诊所的医生和护士为具有较高皮肤风险特征的患者开具了Skinsafe。在基线时以及随访6个月时,从259名接受干预的患者以及5家匹配对照诊所的330名具有较高皮肤风险特征的患者处获取了黑色素瘤知识、黑色素瘤感知风险及报告的皮肤保护行为的测量数据。
参与者在基线时的黑色素瘤知识水平较低。在随访时,干预组的知识得分高于对照组(3.71对3.03,P≤0.001),报告的皮肤保护行为更多(5.36对5.06,P = 0.007),并且更有可能报告进行痣检查(优势比1.67,95%置信区间1.04至2.70,P = 0.035)。患者对Skinsafe干预措施评价积极,可用于支持临床环境中的黑色素瘤健康教育。